What Is Zepbound (Tirzepatide) Used For?
Zepbound™ is an FDA-approved medication for weight loss in adults with a body mass index (BMI) of 30+ kg/m2 or 27+ kg/m2 with weight related medical problems such as high blood pressure, diabetes and high cholesterol in combination with a low calorie diet and increased physical activity. It is a dual GLP-1/GIP* receptor agonist which acts to stimulate the release of insulin by the pancreas which lowers blood sugar levels and improves insulin sensitivity. It can also promote weight loss by decreasing appetite, most effectively used in combination with a healthy diet and increased physical activity. In clinical trials, patients lost at least 5% of their body weight after 3 months with a combination of Zepbound and intensive lifestyle changes. When these individuals took Zepbound for up to a year and a half, they lost an average of 26.6% of their body weight.
*glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP)
Learn more about Zepbound for weight loss at FORM.
Zepbound™ and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Lauren Lemieux, MD
FACP, ABOM diplomate
Dr. Lauren Lemieux completed her Internal Medicine residency and fellowship in Clinical Nutrition at UCLA. She is board certified in Internal Medicine and diplomate of the American Board of Obesity Medicine, and as a Physician Nutrition Specialist. She is also a fellow of the American College of Physicians. Dr. Lemieux is passionate about helping her patients reach their health goals using personalized nutrition, lifestyle and weight management strategies.